Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


3 Clin Infect Dis
1 J Infect
3 J Infect Dis
1 J Virol
1 Lancet
4 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
1 Pediatr Infect Dis J
1 Pediatrics
13 PLoS One
1 Science
36 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


    AstraZeneca's covid-19 (mis)adventure and the future of vaccine equity.
    BMJ. 2022;379:o2592.

    Vaccine access: World's poorest people suffer at the hands of free market dynamics, says WHO.
    BMJ. 2022;379:o2714.

    Clin Infect Dis

  3. MARTIN C, Dauby N
    Guiding yellow fever vaccination strategy worldwide: booster = better?
    Clin Infect Dis. 2022 Nov 16. pii: 6830230. doi: 10.1093.

  4. SHAH MM, Spencer BR, Feldstein LR, Haynes JM, et al
    Occupations Associated with SARS-CoV-2 Infection and Vaccination, U.S. Blood Donors, July 2021-December 2021.
    Clin Infect Dis. 2022 Nov 14. pii: 6825618. doi: 10.1093.
    PubMed         Abstract available

  5. BARDA N, Canetti M, Gilboa M, Asraf K, et al
    The Association Between Pre-Booster Vaccination Antibody Levels and the Risk of SARS-CoV-2 Infection.
    Clin Infect Dis. 2022 Nov 11. pii: 6821340. doi: 10.1093.
    PubMed         Abstract available

    J Infect

  6. MILLER P, Patel SR, Skinner R, Dignan F, et al
    Joint Consensus Statement on the Vaccination of Adult and Paediatric Haematopoietic Stem Cell Transplant Recipients. Prepared on Behalf of the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT), the Children's Cancer an
    J Infect. 2022 Nov 15. pii: S0163-4453(22)00646.
    PubMed         Abstract available

    J Infect Dis

  7. SKOWRONSKI DM, Leir S, Sabaiduc S, Chambers C, et al
    Influenza Vaccine Effectiveness by A(H3N2) Phylogenetic Subcluster and Prior Vaccination History: 2016-2017 and 2017-2018 Epidemics in Canada.
    J Infect Dis. 2022;225:1387-1398.
    PubMed         Abstract available

  8. HOA LNM, Sullivan SG, Mai LQ, Khvorov A, et al
    Influenza A(H1N1)pdm09 But Not A(H3N2) Virus Infection Induces Durable Seroprotection: Results From the Ha Nam Cohort.
    J Infect Dis. 2022;226:59-69.
    PubMed         Abstract available

  9. OKUDA M, Sakai-Tagawa Y, Koga M, Koibuchi T, et al
    Immunological correlates of prevention of the onset of seasonal H3N2 influenza.
    J Infect Dis. 2022 Apr 27. pii: 6574940. doi: 10.1093.
    PubMed         Abstract available

    J Virol

  10. HARWOOD OE, Balgeman AJ, Weaver AJ, Ellis-Connell AL, et al
    Transient T Cell Expansion, Activation, and Proliferation in Therapeutically Vaccinated Simian Immunodeficiency Virus-Positive Macaques Treated with N-803.
    J Virol. 2022 Nov 15:e0142422. doi: 10.1128/jvi.01424.
    PubMed         Abstract available


  11. RUBIN R
    Vaccine Approved in Pregnancy to Protect Young Infants.
    JAMA. 2022;328:1898.

    WHO Backs Single Dose of Hepatitis A Vaccine in Some Cases.
    JAMA. 2022;328:1896.

    Studies Find Single Dose of HPV Vaccines May Be Effective.
    JAMA. 2022;328:1896.

  14. KUEHN BM
    Second COVID-19 Booster Increases Protection for Nursing Home Patients.
    JAMA. 2022;328:1800-1801.


  15. AGUS DB, Nguyen A, Sall AA, Bell J, et al
    COVID-19 and other adult vaccines can drive global disease prevention.
    Lancet. 2022 Oct 27. pii: S0140-6736(22)02084.

    MMWR Morb Mortal Wkly Rep

  16. HAMID S, Woodworth K, Pham H, Milucky J, et al
    COVID-19-Associated Hospitalizations Among U.S. Infants Aged <6 Months - COVID-NET, 13 States, June 2021-August 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1442-1448.
    PubMed         Abstract available

  17. ROSENBLUM HG, Wallace M, Godfrey M, Roper LE, et al
    Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1436-1441.
    PubMed         Abstract available

  18. SANTIBANEZ TA, Zhou T, Black CL, Vogt TM, et al
    Sociodemographic Variation in Early Uptake of COVID-19 Vaccine and Parental Intent and Attitudes Toward Vaccination of Children Aged 6 Months-4 Years - United States, July 1-29, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1479-1484.
    PubMed         Abstract available

  19. KROW-LUCAL E, Marin M, Shepersky L, Bahta L, et al
    Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1465-1470.
    PubMed         Abstract available

    N Engl J Med

  20. RUBIN EJ, Baden LR, Marks P, Morrissey S, et al
    Audio Interview: The FDA and Covid-19 Vaccines.
    N Engl J Med. 2022;387:e60.

    Circulating Poliovirus in New York - New Instance of an Old Problem.
    N Engl J Med. 2022;387:1725-1728.

    Pediatr Infect Dis J

  22. BUONSENSO D, Perramon A, Catala M, Torres JP, et al
    Multisystem Inflammatory Syndrome in Children in Western Countries? Decreasing Incidence as the Pandemic Progresses?: An Observational Multicenter International Cross-sectional Study.
    Pediatr Infect Dis J. 2022;41:989-993.
    PubMed         Abstract available


  23. PATEL KM, Malik AA, Lee A, Klotz M, et al
    COVID-19 Vaccine Uptake Among US Child Care Providers.
    Pediatrics. 2021;148.
    PubMed         Abstract available

    PLoS One

  24. OLUSANYA OA, White B, Malik F, Hester KA, et al
    Healthcare professionals' perceptions and recommendations regarding adolescent vaccinations in Georgia and Tennessee during the COVID-19 pandemic: A qualitative research.
    PLoS One. 2022;17:e0277748.
    PubMed         Abstract available

  25. DARWEESH O, Khatab N, Kheder R, Mohammed T, et al
    Assessment of COVID-19 vaccination among healthcare workers in Iraq; adverse effects and hesitancy.
    PLoS One. 2022;17:e0274526.
    PubMed         Abstract available

  26. HOY C, Wood T, Moscoe E
    Addressing vaccine hesitancy in developing countries: Survey and experimental evidence.
    PLoS One. 2022;17:e0277493.
    PubMed         Abstract available

    Covid-19 vaccines in Italian public opinion: Identifying key issues using Twitter and Natural Language Processing.
    PLoS One. 2022;17:e0277394.
    PubMed         Abstract available

  28. NEWCOMB K, Bilal S, Michael E
    Combining predictive models with future change scenarios can produce credible forecasts of COVID-19 futures.
    PLoS One. 2022;17:e0277521.
    PubMed         Abstract available

  29. BANU B, Akter N, Chowdhury SH, Islam KR, et al
    COVID-19 and Bangladeshi health professionals: Infection status, vaccination and its immediate health consequences.
    PLoS One. 2022;17:e0277022.
    PubMed         Abstract available

  30. PEREZ A, Johnson JK, Marquez DX, Keiser S, et al
    Factors related to COVID-19 vaccine intention in Latino communities.
    PLoS One. 2022;17:e0272627.
    PubMed         Abstract available

  31. LEE H, Noh EB, Kim JE, Oh J, et al
    Influencing factor of COVID-19 vaccination trust and hesitancy in Wonju city, South Korea.
    PLoS One. 2022;17:e0277016.
    PubMed         Abstract available

  32. KAREEM R, Sethi MR, Inayat S, Irfan M, et al
    The effect of COVID-19 vaccination on the menstrual pattern and mental health of the medical students: A mixed-methods study from a low and middle-income country.
    PLoS One. 2022;17:e0277288.
    PubMed         Abstract available

  33. BRACCI A, Nadini M, Aliapoulios M, McCoy D, et al
    Vaccines and more: The response of Dark Web marketplaces to the ongoing COVID-19 pandemic.
    PLoS One. 2022;17:e0275288.
    PubMed         Abstract available

  34. DABROWSKA-LEONIK N, Sawicka-Powierza J, Bernatowska E, Pac M, et al
    Lack of relationship between 25-hydoxyvitamin D concentration and a titer of antibodies to hepatitis B surface antigen in children under 12 years of age.
    PLoS One. 2022;17:e0277473.
    PubMed         Abstract available

  35. TAMIRE M, Addissie A, Gizaw S, Abebe T, et al
    Household fuel use and its association with potential respiratory pathogens among healthy mothers and children in Ethiopia.
    PLoS One. 2022;17:e0277348.
    PubMed         Abstract available

  36. COCCIA M, Burny W, Demoitie MA, Gillard P, et al
    Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses.
    PLoS One. 2022;17:e0276505.
    PubMed         Abstract available


  37. MALE V
    COVID-19 vaccination and menstruation.
    Science. 2022;378:704-706.
    PubMed         Abstract available


  38. BAI Q, Wang Z, An Y, Tian J, et al
    Chitosan-functionalized graphene oxide as adjuvant in HEV P239 vaccine.
    Vaccine. 2022 Nov 9. pii: S0264-410X(22)01375.
    PubMed         Abstract available

  39. MORSTEAD T, Zheng J, Sin NL, DeLongis A, et al
    Perceived threat and coping responses during the COVID-19 pandemic: Prospective associations with vaccine hesitancy.
    Vaccine. 2022 Nov 4. pii: S0264-410X(22)01363.
    PubMed         Abstract available

  40. MALDEN DE, Gee J, Glenn S, Li Z, et al
    Reactions following Pfizer-BioNTech COVID-19 mRNA vaccination and related healthcare encounters among 7,077 children aged 5-11 years within an integrated healthcare system.
    Vaccine. 2022 Nov 3. pii: S0264-410X(22)01361.
    PubMed         Abstract available

  41. HE H, Zhu Y, Jin M, Zhou Y, et al
    The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: A cross-sectional sero-epidemiological study.
    Vaccine. 2022;40:6956-6962.
    PubMed         Abstract available

  42. RANE MS, Rohani P, Halloran ME
    Durability of protection after 5 doses of acellular pertussis vaccine among 5-9 year old children in King County, Washington.
    Vaccine. 2021;39:6144-6150.
    PubMed         Abstract available

  43. ALFANO V, Ercolano S
    Your vaccine attitude determines your altitude. What are the determinants of attitudes toward vaccination?
    Vaccine. 2022;40:6987-6997.
    PubMed         Abstract available

  44. PANICKAN S, Bhatia S, Bhat S, Bhandari N, et al
    Reverse genetics based H5N2 vaccine provides clinical protection against H5N1, H5N8 and H9N2 avian influenza infection in chickens.
    Vaccine. 2022;40:6998-7008.
    PubMed         Abstract available

  45. POURIAYEVALI MH, Teimoori A, Esmaeili S, Abdoli A, et al
    Corrigendum to "Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein" [Vaccine 40(20) (2022) 2856-2868].
    Vaccine. 2022;40:7009.

  46. LUKEHART SA, Molini B, Gomez A, Godornes C, et al
    Immunization with a tri-antigen syphilis vaccine significantly attenuates chancre development, reduces bacterial load, and inhibits dissemination of Treponema pallidum.
    Vaccine. 2022 Nov 11. pii: S0264-410X(22)01372.
    PubMed         Abstract available

  47. QI W, Qingfeng L, Jing Z, Maolin Z, et al
    A novel multi-epitope vaccine of HPV16 E5E6E7 oncoprotein delivered by HBc VLPs induced efficient prophylactic and therapeutic antitumor immunity in tumor mice model.
    Vaccine. 2022 Nov 11. pii: S0264-410X(22)01327.
    PubMed         Abstract available

  48. LOPEZ-DORIGA RUIZ P, Gunnes N, Michael Gran J, Karlstad O, et al
    Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway.
    Vaccine. 2022 Nov 7. pii: S0264-410X(22)01367.
    PubMed         Abstract available

  49. KPOZEHOUEN EB, Tan T, Macintyre CR
    Uptake of influenza, pneumococcal and herpes zoster vaccines among people with heart failure and atrial fibrillation.
    Vaccine. 2022 Nov 12. pii: S0264-410X(22)01377.
    PubMed         Abstract available

  50. JACKSON ML, Phillips CH, Wellwood S, Kiniry E, et al
    Burden of medically attended influenza infection and cases averted by vaccination - United States, 2016/17 through 2018/19 influenza seasons.
    Vaccine. 2022 Nov 12. pii: S0264-410X(22)01397.
    PubMed         Abstract available

  51. FIX J, Vielot NA, Lund JL, Weber DJ, et al
    Patterns of use of recombinant zoster vaccine among commercially-insured immunocompetent and immunocompromised adults 50-64 years old in the United States.
    Vaccine. 2022 Nov 14. pii: S0264-410X(22)01347.
    PubMed         Abstract available

  52. MANANDHAR P, Wannemuehler K, Danovaro-Holliday MC, Nic Lochlainn L, et al
    Use of catch-up vaccinations in the second year of life (2YL) platform to close immunity gaps: A secondary DHS analysis in Pakistan, Philippines, and South Africa.
    Vaccine. 2022 Nov 14. pii: S0264-410X(22)01301.
    PubMed         Abstract available

  53. HANSEN J, Yee A, Lewis N, Li S, et al
    Safety of 9-valent human papillomavirus vaccine administered to males and females in routine use.
    Vaccine. 2022 Nov 14. pii: S0264-410X(22)01395.
    PubMed         Abstract available

  54. ATTWELL K, Rizzi M, Paul KT
    Consolidating a research agenda for vaccine mandates.
    Vaccine. 2022 Nov 14. pii: S0264-410X(22)01384.
    PubMed         Abstract available

  55. TURBYFILL C, Adams K, Tenforde MW, Murray NL, et al
    Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.
    Vaccine. 2022;40:6979-6986.
    PubMed         Abstract available

  56. KULKARNI AV, Jaggaiahgari S, Iyengar S, Simhadri V, et al
    Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients.
    Vaccine. 2022;40:6971-6978.
    PubMed         Abstract available

  57. MOORE KL, Tan L
    Preferential recommendations for vaccines: Time for a structured, transparent process.
    Vaccine. 2022;40:6893-6894.

  58. KIRTLAND KA, Raghunathan T, Patel Murthy B, Li J, et al
    Estimating vaccination coverage for routinely recommended vaccines among children aged 24months and adolescents aged 13 through 17years using data from immunization information systems in the United States.
    Vaccine. 2022 Nov 7. pii: S0264-410X(22)01341.
    PubMed         Abstract available

  59. OSOWICKI J, Morgan HJ, Harris A, Clothier HJ, et al
    Guillain-Barre syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.
    Vaccine. 2022 Nov 7. pii: S0264-410X(22)01366.
    PubMed         Abstract available

  60. NAEIM A, Guerin RJ, Baxter-King R, Okun AH, et al
    Strategies to increase the intention to get vaccinated against COVID-19: Findings from a nationally representative survey of US adults, October 2020 to October 2021.
    Vaccine. 2022 Sep 12. pii: S0264-410X(22)01117.
    PubMed         Abstract available

  61. HAO XB, Anand M, Wang TR, Rao AR, et al
    Reducing COVID vaccine hesitancy by inducing a comparative mindset.
    Vaccine. 2022 Nov 7. pii: S0264-410X(22)01359.
    PubMed         Abstract available

  62. CRUZ MC, Nascimento-Carvalho CM
    The early evolution of COVID-19 incidence and mortality among people aged under 80 years or 80 years and above after COVID-19 vaccine implementation in the state of Bahia, Brazil.
    Vaccine. 2022 Oct 31. pii: S0264-410X(22)01335.
    PubMed         Abstract available

  63. TRENTELMAN JJA, de Vogel FA, Colstrup E, Sima R, et al
    Identification of novel conserved Ixodes vaccine candidates; a promising role for non-secreted salivary gland proteins.
    Vaccine. 2022 Nov 8. pii: S0264-410X(22)01292.
    PubMed         Abstract available

  64. MARSHALL T, Addison M, Crawford NW, Buttery JP, et al
    Aiming too high: Shoulder injury related to vaccine administration (SIRVA): A case series.
    Vaccine. 2022 Nov 8. pii: S0264-410X(22)01368.
    PubMed         Abstract available

  65. HASHIMOTO M, Aoe S, Kawazu Y, Seki NM, et al
    Homologous and heterologous booster vaccinations of S-268019-b, a recombinant S protein-based vaccine with a squalene-based adjuvant, enhance neutralization breadth against SARS-CoV-2 Omicron subvariants in cynomolgus macaques.
    Vaccine. 2022 Nov 8. pii: S0264-410X(22)01379.
    PubMed         Abstract available

  66. MALTEZOU HC, Gamaletsou MN, Koukou DM, Giannouchos TV, et al
    Association between COVID-19 vaccination status, time elapsed since the last vaccine dose, morbidity, and absenteeism among healthcare personnel: A prospective, multicenter study.
    Vaccine. 2022 Oct 26. pii: S0264-410X(22)01304.
    PubMed         Abstract available

  67. BEALE S, Burns R, Braithwaite I, Byrne T, et al
    Occupation, Worker Vulnerability, and COVID-19 Vaccination Uptake: Analysis of the Virus Watch prospective cohort study.
    Vaccine. 2022 Nov 7. pii: S0264-410X(22)01362.
    PubMed         Abstract available

  68. SKAWRAN S, Schiesser H, Maurer A, Sartoretti T, et al
    Frequency and temporal evolution of COVID-19 vaccination rate among oncological patients undergoing 18F-FDG-PET.
    Vaccine. 2022 Nov 7. pii: S0264-410X(22)01376.
    PubMed         Abstract available

  69. TOMPKINS LK, Baggs J, Myers TR, Gee JM, et al
    Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults.
    Vaccine. 2022 Nov 1. pii: S0264-410X(22)01342.
    PubMed         Abstract available

  70. WU YY, Zhang W
    Demographic disparities in COVID-19 vaccine hesitancy among U.S. adults: Analysis of household pulse survey data from Jul 21 to Oct 11 in 2021.
    Vaccine. 2022 Nov 7. pii: S0264-410X(22)01381.
    PubMed         Abstract available

  71. CHANG CT, Lim XJ, Chew CC, Rajan P, et al
    Preferences and willingness of accepting COVID-19 vaccine booster: Results from a middle-income country.
    Vaccine. 2022 Nov 1. pii: S0264-410X(22)01334.
    PubMed         Abstract available

  72. YU Z, Keskinocak P, Sokol J, Chen YH, et al
    Flexible analytic model to inform multi-stakeholder pediatric vaccine scheduling decisions.
    Vaccine. 2022 Nov 9. pii: S0264-410X(22)01198.
    PubMed         Abstract available

  73. TAKEUCHI Y, Iwagami M, Ono S, Michihata N, et al
    A post-marketing safety assessment of COVID-19 mRNA vaccination for serious adverse outcomes using administrative claims data linked with vaccination registry in a city of Japan.
    Vaccine. 2022 Nov 7. pii: S0264-410X(22)01370.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.